[144] Hyliion Holdings Corp. SEC Filing
Hyliion Holdings (HYLN) has a Form 144 notice indicating a planned sale of 159,776 shares of common stock through UBS Financial Services Inc. on the NYSE. The shares have an aggregate market value of 265,000, versus 175,974,228 common shares outstanding. The securities are reported as acquired on 11/17/2025 via an employee benefit transaction from Hyliion Holdings, with payment described as cash. The person signing the notice represents that they are not aware of undisclosed material adverse information about Hyliion’s current or prospective operations.
- None.
- None.
FAQ
What does Hyliion (HYLN) disclose in this Form 144 filing?
The Form 144 notice for Hyliion (HYLN) reports a planned sale of 159,776 shares of common stock on the NYSE through UBS Financial Services Inc., with an aggregate market value of 265,000.
How many Hyliion (HYLN) shares are proposed to be sold under this Form 144?
The notice covers a proposed sale of 159,776 shares of Hyliion common stock, to be sold through UBS Financial Services Inc. on the NYSE.
What is the aggregate market value of the Hyliion shares in this Form 144?
The Form 144 indicates an aggregate market value of 265,000 for the 159,776 Hyliion common shares proposed to be sold.
How many Hyliion (HYLN) shares were outstanding according to this notice?
The Form 144 states that there were 175,974,228 shares of Hyliion common stock outstanding, providing context for the size of the proposed sale.
When and how were the Hyliion shares in this Form 144 acquired?
The shares are reported as acquired on 11/17/2025 in an employee benefit transaction from Hyliion Holdings, with the nature of payment described as cash.
What representation does the seller make in this Hyliion Form 144?
The person for whose account the securities are to be sold represents that they do not know of any material adverse information about Hyliion’s current or prospective operations that has not been publicly disclosed.